Follicum AB (“Follicum” or “the company”) announced today that the company will attend a conference in Basel (www.basle-manchester-forum.science) and will also sponsor the conference with a small amount of money. Since the German research group who generated important parts of Follicum’s research data on human skin and human hair follicles will attend the conference, this […]
We like as many of our shareholders and other stakeholders to receive our newsletters. Please find an application on our homepage to register your email for regular updates.
Read the latest newsletter from Follicum here.
An analysis of Follicum AB, conducted by the Swedish Shareholders’ Association, has been published today. The document is only available in Swedish. >Anaysis of Follicum (in Swedish) For more information, please contact: Jan Alenfall, CEO Tel: +46 (0)46 19 21 97 Email: firstname.lastname@example.org
On 16 March, CEO Jan Alenfall will present Follicum at Sedermeradagen in Lund at 16.20-16.50. Sedermeradagen offers an opportunity for investors to meet with companies in the micro- and smallcap segment in Sweden. More information in Swedish
Follicum appoints Maria Ekblad Director R&D as of January 2016. Maria Ekblad has more than twenty years of experience from the pharmaceutical industry where she has held various management positions; the latest as Director Preclinical Development at Active Biotech AB in Lund. At Follicum Ekblad will be responsible for the preclinical development as well as […]
Follicum report from World Conference on Hair Research, November 18-21, 2015 in Miami, USA by CEO Jan Alenfall The 2015 WCHR Scientific meeting has the overall goal of presenting new research, sharing experiences, and discussing the advancement and knowledge of hair growth as well as skin-, hair- and scalp diseases. In addition it is a […]
Follicum attended the French Swedish Life Science Day 2015 on 20 October in Paris. The company presented their research projects and had the opportunity to meet with investors and representatives from pharmaceutical companies. The purpose of the meetings was to initiate contacts for future capital investments and potential collaborations. There was significant interest in Follicum’s drug candidates.
Follicum has received a preliminary approval – a so called “Intention to Grant” – by the European Patent Office (EPO) regarding the company’s patent application for stimulation of hair growth. To read the full press release (in Swedish) please click here. For more information about Follicum’s research results, please contact: Jan Alenfall, CEO Tel +46 (0)46 19 21 […]
The German research group which has generated important parts of Follicum’s research data on human skin will present their results both as a poster and in an oral presentation at the World Congress for Hair Research. The congress takes place in Miami in Florida, USA, on 18-21 November 2015. To read the full press release […]